The cannabis investment space has remained quite spread out throughout the past few years as new companies continue to come into the market. In that time, we have seen values shoot up as well as a shift in the public perception regarding the substance. Because of all these changes, it can at times be difficult to keep up with where the market may potentially be headed. With all of this information, there are a few companies that continue to come to mind for their commitment to innovation and in producing new products and services for the world of cannabis.
Biome Grow Inc. (BIOIF/BIO.CN) is considered to be one of the leaders in the Canadian cannabis market. The company recently announced that they have worked to open the door for investors from the U.S. cannabis market. Biome Grow just became available to be traded on the U.S. OTC market, which is where the vast majority of small-cap cannabis companies have moved to.
Khurram Malik, CEO of the company stated that “we are excited to upgrade Biome’s U.S. listing to the OTCQB Venture Market. This is an important step and milestone for the company as it aims to increase its presence among American retail and institutional investors. This move will provide investors with additional liquidity and increased trading capacity.”
The Canadian cannabis market has quickly become the place of focus for many of the more prominent marijuana stocks. With so many companies currently listed on the Canadian Securities Exchange or CSE, it seems as though the access to U.S. exchanges is all but limited. This, however, is beginning to shift as companies like Biome Grow Inc. set the example for how a cannabis company working out of Canada can receive U.S. investments.
Biome Grow is working heavily to show that their diverse portfolio of investments is making them one of the leading cannabis conglomerates. The company has a large series of investments across the various different facets of the cannabis market including luxury and recreational aspects of the industry. Because of this broad scope, it looks as though they could continue to see some successes in the not too distant future, but only time will tell.
Trulieve Cannabis (NASDAQOTH:TCNNF) is one of the leaders in the U.S. cannabis market including that of Florida and Massachusetts/California. Their expansion beyond the Floridian market has been through the use of strategic acquisitions. Recently, the company announced that they have opened their 27th dispensary in the Sunshine State, which is quite a big milestone.
Much of their success has been attributed to the elderly population in the state that uses medicinal marijuana to deal with the complications of aging. The company was able to produce as much as $102 million in sales back in 2018 with an operating profit just shy of $38 million. Trulieve Cannabis continues to show what investing in the alternate U.S. cannabis space can potentially be like.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Biome Grow, Midam is being paid a total of $240,000 ($20,000 per month) for a period beginning on October 1, 2018, and ending on October 1, 2019. We own 0 shares of Biome Grow (BIO.CN). We may buy or sell additional shares of Biome Grow in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Biome Grow (BIO.CN).